ScreenerHero

OSSD OssDsign AB (publ)

STO · SE · Healthcare · Medical Devices · ossdsign.com
3.500SEK+0.43%Mkt Cap: 37.04M $P/E: —

OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States. The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone forma…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$170.98BUSDP/E 31.7
MDT
Medtronic plc
$111.40BUSDP/E 21.4
SYK
Stryker Corporation
$106.71BUSDP/E 28.8
BSX
Boston Scientific Corporation
$61.14BUSDP/E 17.1
EW
Edwards Lifesciences Corporation
$49.80BUSDP/E 51.5
SHL
Siemens Healthineers AG
$46.31BUSDP/E 19.3
DXCM
DexCom, Inc.
$31.47BUSDP/E 33.1
GEHC
GE HealthCare Technologies Inc.
$29.46BUSDP/E 14.9
PHIA
Koninklijke Philips N.V.
$22.91BUSDP/E 18.7
PHG
Koninklijke Philips N.V.
$23.60BUSDP/E 18.0
STE
STERIS plc
$20.34BUSDP/E 25.5
SOON
Sonova Holding AG
$17.13BUSDP/E 28.0
ZBH
Zimmer Biomet Holdings, Inc.
$17.11BUSDP/E 21.8
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
SNN
Smith & Nephew plc
$11.25BUSDP/E 18.3
TXG
10x Genomics, Inc.
$10.51BUSD
GMED
Globus Medical, Inc.
$10.26BUSDP/E 19.6
DEMANT
Demant A/S
$9.97BUSDP/E 28.3
BIO
Bio-Rad Laboratories, Inc.
$9.87BUSDP/E 46.7
GKOS
Glaukos Corporation
$9.53BUSD

Key Statistics

Company
Market Cap37.04M USD
Enterprise Value23.01M USD
Revenue (TTM)15.67M USD
Gross Profit16.59M USD
Net Income (TTM)-4.88M USD
Revenue/Share1.56 SEK
Last Price3.500 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees41
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0012570448
Valuation
P/E (Trailing)—
P/E (Forward)-7.71
PEG—
EV/EBITDA-4.69
EV/Revenue1.47
P/S2.39
P/B1.36
EPS (TTM)-0.50
EPS (Forward)-0.46
52W Range
3.3351% of range14.58
52W High14.58 SEK
52W Low3.335 SEK
Profitability
Gross Margin96.29%
Oper. Margin-32.69%
EBITDA Margin-31.34%
Profit Margin-28.30%
ROE-16.45%
ROA-12.82%
Growth
Revenue Growth-18.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.12M USD
CapEx (TTM)707.83K USD
FCF Margin-27.18%
FCF Yield-11.50%
Net Debt-14.50M USD
Net Debt/EBITDA2.95
Balance Sheet
Debt/Equity0.00
Current Ratio7.30
Quick Ratio6.31
Book Value/Sh2.60 SEK
Cash/Share1.38 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.500 SEK
Upside (mean)+85.7%
Target Range5.000 SEK – 8.000 SEK
5.000+85.7% to mean8.000
# Analysts2
Ownership
Shares Out.110.63M
Float78.05M
Insiders14.08%
Institutions31.66%
Technical
SMA 503.845 (-9.0%)
SMA 2005.408 (-35.3%)
Beta0.64
S&P 52W Chg14.58%
Avg Vol (30d)209.09K
Avg Vol (10d)232.66K
Technical Indicators
RSI (14)42.3
MACD-0.0780
MACD Signal-0.0919
MACD Hist.+0.0139
BB Upper3.729 SEK
BB Middle3.559 SEK
BB Lower3.389 SEK
BB Width9.55%
ATR (14)0.1661 SEK
Vol Ratio (20d)1.16x